-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Beam Therapeutics (NASDAQ:BEAM) Given Buy Rating at HC Wainwright
Beam Therapeutics (NASDAQ:BEAM – Get Free Report)‘s stock had its “buy” rating reiterated by HC Wainwright in a research report issued on Friday,Benzinga reports. They currently have a $80.00 price target on the stock. HC Wainwright’s price target points to a potential upside of 203.72% from the company’s current price. A number of other research […]
Beam Therapeutics (NASDAQ:BEAM – Get Free Report)‘s stock had its “buy” rating reiterated by HC Wainwright in a research report issued on Friday,Benzinga reports. They currently have a $80.00 price target on the stock. HC Wainwright’s price target points to a potential upside of 203.72% from the company’s current price. A number of other research […]
